img

Global Children Influenza Vaccine Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Children Influenza Vaccine Market Research Report 2024

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
According to Mr Accuracy reports new survey, global Children Influenza Vaccine market is projected to reach US$ 2090.9 million in 2029, increasing from US$ 1597 million in 2022, with the CAGR of 3.9% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Children Influenza Vaccine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Children Influenza Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Sanofi
CSL
GSK
Viatris
Hulan Bio
AstraZeneca
CCBIO
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Segment by Type
Nasal Spray
Injection

Segment by Application


Public
Private

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Children Influenza Vaccine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Children Influenza Vaccine Market Overview
1.1 Product Overview and Scope of Children Influenza Vaccine
1.2 Children Influenza Vaccine Segment by Type
1.2.1 Global Children Influenza Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Nasal Spray
1.2.3 Injection
1.3 Children Influenza Vaccine Segment by Application
1.3.1 Global Children Influenza Vaccine Market Value by Application: (2024-2034)
1.3.2 Public
1.3.3 Private
1.4 Global Children Influenza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Children Influenza Vaccine Revenue 2018-2029
1.4.2 Global Children Influenza Vaccine Sales 2018-2029
1.4.3 Global Children Influenza Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Children Influenza Vaccine Market Competition by Manufacturers
2.1 Global Children Influenza Vaccine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Children Influenza Vaccine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Children Influenza Vaccine Average Price by Manufacturers (2018-2024)
2.4 Global Children Influenza Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Children Influenza Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Children Influenza Vaccine, Product Type & Application
2.7 Children Influenza Vaccine Market Competitive Situation and Trends
2.7.1 Children Influenza Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Children Influenza Vaccine Players Market Share by Revenue
2.7.3 Global Children Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Children Influenza Vaccine Retrospective Market Scenario by Region
3.1 Global Children Influenza Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Children Influenza Vaccine Global Children Influenza Vaccine Sales by Region: 2018-2029
3.2.1 Global Children Influenza Vaccine Sales by Region: 2018-2024
3.2.2 Global Children Influenza Vaccine Sales by Region: 2024-2029
3.3 Global Children Influenza Vaccine Global Children Influenza Vaccine Revenue by Region: 2018-2029
3.3.1 Global Children Influenza Vaccine Revenue by Region: 2018-2024
3.3.2 Global Children Influenza Vaccine Revenue by Region: 2024-2029
3.4 North America Children Influenza Vaccine Market Facts & Figures by Country
3.4.1 North America Children Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Children Influenza Vaccine Sales by Country (2018-2029)
3.4.3 North America Children Influenza Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Children Influenza Vaccine Market Facts & Figures by Country
3.5.1 Europe Children Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Children Influenza Vaccine Sales by Country (2018-2029)
3.5.3 Europe Children Influenza Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Children Influenza Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Children Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Children Influenza Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Children Influenza Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Children Influenza Vaccine Market Facts & Figures by Country
3.7.1 Latin America Children Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Children Influenza Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Children Influenza Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Children Influenza Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Children Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Children Influenza Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Children Influenza Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Children Influenza Vaccine Sales by Type (2018-2029)
4.1.1 Global Children Influenza Vaccine Sales by Type (2018-2024)
4.1.2 Global Children Influenza Vaccine Sales by Type (2024-2029)
4.1.3 Global Children Influenza Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Children Influenza Vaccine Revenue by Type (2018-2029)
4.2.1 Global Children Influenza Vaccine Revenue by Type (2018-2024)
4.2.2 Global Children Influenza Vaccine Revenue by Type (2024-2029)
4.2.3 Global Children Influenza Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Children Influenza Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Children Influenza Vaccine Sales by Application (2018-2029)
5.1.1 Global Children Influenza Vaccine Sales by Application (2018-2024)
5.1.2 Global Children Influenza Vaccine Sales by Application (2024-2029)
5.1.3 Global Children Influenza Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Children Influenza Vaccine Revenue by Application (2018-2029)
5.2.1 Global Children Influenza Vaccine Revenue by Application (2018-2024)
5.2.2 Global Children Influenza Vaccine Revenue by Application (2024-2029)
5.2.3 Global Children Influenza Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Children Influenza Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Sanofi Children Influenza Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 CSL Children Influenza Vaccine Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 GSK Children Influenza Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Corporation Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Viatris Children Influenza Vaccine Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 Hulan Bio
6.5.1 Hulan Bio Corporation Information
6.5.2 Hulan Bio Description and Business Overview
6.5.3 Hulan Bio Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Hulan Bio Children Influenza Vaccine Product Portfolio
6.5.5 Hulan Bio Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.6.4 AstraZeneca Children Influenza Vaccine Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 CCBIO
6.6.1 CCBIO Corporation Information
6.6.2 CCBIO Description and Business Overview
6.6.3 CCBIO Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 CCBIO Children Influenza Vaccine Product Portfolio
6.7.5 CCBIO Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Corporation Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Sinovac Children Influenza Vaccine Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 BCHT
6.9.1 BCHT Corporation Information
6.9.2 BCHT Description and Business Overview
6.9.3 BCHT Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.9.4 BCHT Children Influenza Vaccine Product Portfolio
6.9.5 BCHT Recent Developments/Updates
6.10 Jiangsu GDK
6.10.1 Jiangsu GDK Corporation Information
6.10.2 Jiangsu GDK Description and Business Overview
6.10.3 Jiangsu GDK Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Jiangsu GDK Children Influenza Vaccine Product Portfolio
6.10.5 Jiangsu GDK Recent Developments/Updates
6.11 KM Biologics
6.11.1 KM Biologics Corporation Information
6.11.2 KM Biologics Children Influenza Vaccine Description and Business Overview
6.11.3 KM Biologics Children Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.11.4 KM Biologics Children Influenza Vaccine Product Portfolio
6.11.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Children Influenza Vaccine Industry Chain Analysis
7.2 Children Influenza Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Children Influenza Vaccine Production Mode & Process
7.4 Children Influenza Vaccine Sales and Marketing
7.4.1 Children Influenza Vaccine Sales Channels
7.4.2 Children Influenza Vaccine Distributors
7.5 Children Influenza Vaccine Customers
8 Children Influenza Vaccine Market Dynamics
8.1 Children Influenza Vaccine Industry Trends
8.2 Children Influenza Vaccine Market Drivers
8.3 Children Influenza Vaccine Market Challenges
8.4 Children Influenza Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Children Influenza Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Children Influenza Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Children Influenza Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Children Influenza Vaccine Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Children Influenza Vaccine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Children Influenza Vaccine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Children Influenza Vaccine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Children Influenza Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Children Influenza Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Children Influenza Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Children Influenza Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Children Influenza Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Children Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Children Influenza Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Children Influenza Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Children Influenza Vaccine Sales by Region (2018-2024) & (K Units)
Table 18. Global Children Influenza Vaccine Sales Market Share by Region (2018-2024)
Table 19. Global Children Influenza Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global Children Influenza Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Children Influenza Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Children Influenza Vaccine Revenue Market Share by Region (2018-2024)
Table 23. Global Children Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Children Influenza Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Children Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Children Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 27. North America Children Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America Children Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Children Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Children Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Children Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 32. Europe Children Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Children Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Children Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Children Influenza Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Children Influenza Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Children Influenza Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Children Influenza Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Children Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Children Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Children Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Children Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Children Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Children Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Children Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Children Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Children Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Children Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Children Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Children Influenza Vaccine Sales (K Units) by Type (2018-2024)
Table 51. Global Children Influenza Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global Children Influenza Vaccine Sales Market Share by Type (2018-2024)
Table 53. Global Children Influenza Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Children Influenza Vaccine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Children Influenza Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Children Influenza Vaccine Revenue Market Share by Type (2018-2024)
Table 57. Global Children Influenza Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Children Influenza Vaccine Price (US$/Unit) by Type (2018-2024)
Table 59. Global Children Influenza Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Children Influenza Vaccine Sales (K Units) by Application (2018-2024)
Table 61. Global Children Influenza Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global Children Influenza Vaccine Sales Market Share by Application (2018-2024)
Table 63. Global Children Influenza Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Children Influenza Vaccine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Children Influenza Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Children Influenza Vaccine Revenue Market Share by Application (2018-2024)
Table 67. Global Children Influenza Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Children Influenza Vaccine Price (US$/Unit) by Application (2018-2024)
Table 69. Global Children Influenza Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Sanofi Children Influenza Vaccine Product
Table 74. Sanofi Recent Developments/Updates
Table 75. CSL Corporation Information
Table 76. CSL Description and Business Overview
Table 77. CSL Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. CSL Children Influenza Vaccine Product
Table 79. CSL Recent Developments/Updates
Table 80. GSK Corporation Information
Table 81. GSK Description and Business Overview
Table 82. GSK Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. GSK Children Influenza Vaccine Product
Table 84. GSK Recent Developments/Updates
Table 85. Viatris Corporation Information
Table 86. Viatris Description and Business Overview
Table 87. Viatris Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Viatris Children Influenza Vaccine Product
Table 89. Viatris Recent Developments/Updates
Table 90. Hulan Bio Corporation Information
Table 91. Hulan Bio Description and Business Overview
Table 92. Hulan Bio Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Hulan Bio Children Influenza Vaccine Product
Table 94. Hulan Bio Recent Developments/Updates
Table 95. AstraZeneca Corporation Information
Table 96. AstraZeneca Description and Business Overview
Table 97. AstraZeneca Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. AstraZeneca Children Influenza Vaccine Product
Table 99. AstraZeneca Recent Developments/Updates
Table 100. CCBIO Corporation Information
Table 101. CCBIO Description and Business Overview
Table 102. CCBIO Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. CCBIO Children Influenza Vaccine Product
Table 104. CCBIO Recent Developments/Updates
Table 105. Sinovac Corporation Information
Table 106. Sinovac Description and Business Overview
Table 107. Sinovac Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Sinovac Children Influenza Vaccine Product
Table 109. Sinovac Recent Developments/Updates
Table 110. BCHT Corporation Information
Table 111. BCHT Description and Business Overview
Table 112. BCHT Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. BCHT Children Influenza Vaccine Product
Table 114. BCHT Recent Developments/Updates
Table 115. Jiangsu GDK Corporation Information
Table 116. Jiangsu GDK Description and Business Overview
Table 117. Jiangsu GDK Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Jiangsu GDK Children Influenza Vaccine Product
Table 119. Jiangsu GDK Recent Developments/Updates
Table 120. KM Biologics Corporation Information
Table 121. KM Biologics Description and Business Overview
Table 122. KM Biologics Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. KM Biologics Children Influenza Vaccine Product
Table 124. KM Biologics Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Children Influenza Vaccine Distributors List
Table 128. Children Influenza Vaccine Customers List
Table 129. Children Influenza Vaccine Market Trends
Table 130. Children Influenza Vaccine Market Drivers
Table 131. Children Influenza Vaccine Market Challenges
Table 132. Children Influenza Vaccine Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Children Influenza Vaccine
Figure 2. Global Children Influenza Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Children Influenza Vaccine Market Share by Type in 2022 & 2029
Figure 4. Nasal Spray Product Picture
Figure 5. Injection Product Picture
Figure 6. Global Children Influenza Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Children Influenza Vaccine Market Share by Application in 2022 & 2029
Figure 8. Public
Figure 9. Private
Figure 10. Global Children Influenza Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Children Influenza Vaccine Market Size (2018-2029) & (US$ Million)
Figure 12. Global Children Influenza Vaccine Sales (2018-2029) & (K Units)
Figure 13. Global Children Influenza Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 14. Children Influenza Vaccine Report Years Considered
Figure 15. Children Influenza Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Children Influenza Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Children Influenza Vaccine Players: Market Share by Revenue in 2022
Figure 18. Children Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Children Influenza Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Children Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 21. North America Children Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 22. United States Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Children Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 25. Europe Children Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 26. Germany Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Children Influenza Vaccine Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Children Influenza Vaccine Revenue Market Share by Region (2018-2029)
Figure 33. China Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Children Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 43. Latin America Children Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Children Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Children Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Children Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Children Influenza Vaccine by Type (2018-2029)
Figure 53. Global Revenue Market Share of Children Influenza Vaccine by Type (2018-2029)
Figure 54. Global Children Influenza Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Children Influenza Vaccine by Application (2018-2029)
Figure 56. Global Revenue Market Share of Children Influenza Vaccine by Application (2018-2029)
Figure 57. Global Children Influenza Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 58. Children Influenza Vaccine Value Chain
Figure 59. Children Influenza Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries